Erik Harris

(Mr. Erik Harris)

Currently holds a position at Ultragenyx Pharmaceutical Inc

Positions
Position Company Period
Executive Vice President and Chief Commercial Officer Ultragenyx Pharmaceutical Inc June 17, 2019 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-05 2024-03-01
PS Planned sale
4,768 -6.6%
53.76
256,328 USD 		4,768 -6.6% 53.76 256,328 USD
2023-09-06 2023-09-05
S Sale
6,000 -10.5%
37.96
227,760 USD 		6,000 -10.5% 37.96 227,760 USD
2023-03-03 2023-03-01
PS Planned sale
3,664 -6.0%
45.25
165,796 USD 		3,664 -6.0% 45.25 165,796 USD
2022-06-22 2022-06-19
PS Planned sale
295 -0.8%
54.78
16,160 USD 		295 -0.8% 54.78 16,160 USD
2022-03-03 2022-03-01
S Sale
2,713 -10.8%
66.62
180,740 USD 		2,713 -10.8% 66.62 180,740 USD
2021-10-18 2021-10-14
S Sale
303 -1.2%
81.14
24,585 USD 		303 -1.2% 81.14 24,585 USD
2021-07-08 2021-07-06
S Sale
375 -1.5%
91.53
34,324 USD 		375 -1.5% 91.53 34,324 USD
2021-06-23 2021-06-21
PS Planned sale
572 -2.2%
94.96
54,317 USD 		572 -2.2% 94.96 54,317 USD
2021-06-23 2021-06-19
S Sale
437 -1.6%
94.63
41,353 USD 		437 -1.6% 94.63 41,353 USD
2021-05-10 2021-05-07
PS Planned sale
393 -1.4%
113.67
44,672 USD 		393 -1.4% 113.67 44,672 USD
2021-05-10 2021-05-06
S Sale
307 -1.1%
113.68
34,900 USD 		307 -1.1% 113.68 34,900 USD
2021-04-21 2021-04-20
PS Planned sale
396 -1.4%
104.28
41,295 USD 		396 -1.4% 104.28 41,295 USD
2021-03-03 2021-03-02
PS Planned sale
707 -2.5%
138.16
97,679 USD 		707 -2.5% 138.16 97,679 USD
2021-03-03 2021-03-01
S Sale
2,470 -8.0%
138.17
341,280 USD 		2,470 -8.0% 138.17 341,280 USD
2020-10-16 2020-10-14
S Sale
220 -0.9%
88.00
19,360 USD 		220 -0.9% 88.00 19,360 USD
2021-02-03 2020-06-03
S Sale
2,516 -10.8%
74.69
187,920 USD 		2,516 -10.8% 74.69 187,920 USD